Furthermore, IL‐17A and Th17 cells have been implicated in the progression of non‐alcoholic steatohepatitis (NASH) to HCC, highlighting their role in tumor angiogenesis and inflammation‐driven carcinogenesis [23]. The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatohepatitis.